Page 21 - U.S. Growth Pharmaceuticals & Biotech Stocks

UPDATED Apr 12, 2026

Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

711 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
MBX
US$31.00-6.0%318.4%US$1.5bUS$62.554.0-5.3%n/a
DMAC
US$5.99-7.6%72.6%US$322.8mUS$15.505.8-5.5%n/a
CALC
US$0.625.6%-59.8%US$9.7mUS$10.33-0.3-5.7%n/a
ARTV
US$6.811.0%243.9%US$168.3mUS$17.001.5-5.7%n/a
BOLD
US$1.134.6%-7.4%US$25.3mUS$4.000.3-6.1%n/a
CRBU
US$1.93-0.5%120.7%US$186.5mUS$11.1316.7-6.2%n/a
KYTX
US$8.95-0.3%301.3%US$541.1mUS$29.602.3-6.3%n/a
EIKN
US$9.00-9.1%n/aUS$487.2mUS$25.60-1.5-6.4%n/a
ERAS
US$17.01-4.5%1,271.8%US$5.3bUS$18.1016.3-6.7%n/a
BEAM
US$27.4311.2%77.3%US$2.7bUS$51.2019.5-6.9%n/a
OKUR
US$4.300.2%45.8%US$58.8mUS$20.201.0-7.2%n/a
TERN
US$52.63-0.2%2,359.3%US$6.1bUS$53.636.0-7.3%n/a
ZURA
US$5.65-6.3%366.9%US$536.1mUS$15.505.3-7.4%n/a
CRBP
US$9.80-3.6%62.3%US$173.8mUS$40.561.2-7.5%n/a
DMRA
US$25.822.9%1,012.9%US$1.6bUS$46.20-7.4-7.5%n/a
VYGR
US$3.74-5.8%17.2%US$222.9mUS$14.895.5-7.7%n/a
GLSI
US$25.7813.0%161.5%US$357.2mUS$47.50163.5-8.1%n/a
ABOS
US$2.47-8.5%122.5%US$178.4mUS$7.402.5-8.5%n/a
ACRS
US$4.046.3%242.4%US$561.5mUS$8.2971.8-8.5%n/a
SANA
US$3.09-3.4%75.6%US$824.6mUS$8.435.1-8.6%n/a
SGMT
US$5.303.1%122.7%US$172.7mUS$25.781.6-8.7%n/a
MGX
US$1.381.5%-9.2%US$51.9mUS$9.332.1-9.0%n/a
BMEA
US$1.8721.4%6.9%US$135.2mUS$7.174.6-9.2%n/a
MAZE
US$26.69-7.0%240.9%US$1.3bUS$64.823.7-9.4%n/a
Page 21 of 30